Health Care & Life Sciences » Pharmaceuticals | AstraZeneca Pharma India Ltd.

AstraZeneca Pharma India Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
4,736
4,690
5,637
5,437
5,710
Cost of Goods Sold (COGS) incl. D&A
3,703
3,955
4,148
3,931
4,055
Gross Income
1,034
734
1,489
1,506
1,656
SG&A Expense
1,213
1,435
1,462
1,199
1,301
EBIT
233
747
-
-
342
Unusual Expense
139
5
-
-
22
Non Operating Income/Expense
52
489
7
79
5
Pretax Income
-
208
58
355
438
Income Tax
5
-
5
155
179
Consolidated Net Income
5
208
53
201
259
Net Income
5
208
53
201
259
Net Income After Extraordinaries
5
208
53
201
259
Net Income Available to Common
5
208
53
201
259
EPS (Basic)
0.20
8.34
2.10
8.00
10.40
Basic Shares Outstanding
25
25
25
25
25
EPS (Diluted)
0.20
8.34
2.10
8.02
10.36
Diluted Shares Outstanding
25
25
25
25
25
EBITDA
132
594
167
375
489
Other Operating Expense
54
46
34
91
13
Non-Operating Interest Income
42
44
58
60
113

About AstraZeneca Pharma India

View Profile
Address
Block N1, 12th Floor
Bangalore Karnataka 560045
India
Employees -
Website http://www.astrazeneca.com/country-sites/india.html
Updated 09/14/2018
AstraZeneca Pharma India Ltd. engages in the manufacture, distribution, and marketing of pharmaceutical products and clinical trial services. It focuses in the areas of cardiovascular/metabolic disease, cancer and respiratory, inflammatory, and autoimmune disease. The company was founded on July 11, 1979 and is headquartered in Bangalore, India.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.